Edouard Benit

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Giuseppe De Luca, Monica Verdoia, Miha Čerček et al. · Journal of the American College of Cardiology · 2020 · 204 citations · Full text

Transplantation, Mechanical Reperfusion, Covid-19 Pandemic +3

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

Giuseppe De Luca, Sander A.J. Damen, Cyril Camaro et al. · EuroIntervention · 2019 · 175 citations

A Randomized Trial of Recombinant Staphylokinase Versus Alteplase for Coronary Artery Patency in Acute Myocardial Infarction

Steven Vanderschueren, Laurentino Barrios, Pitsanu Kerdsinchai et al. · Circulation · 1995 · 168 citations

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

Clemens von Birgelen, Paolo Zocca, Rosaly A. Buiten et al. · The Lancet · 2018 · 145 citations · Full text

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +7